Orion returns at Frontiers Health 2022 to unleash the power of digital therapeutics for chronic pain
We are happy that Orion will join us again as a conference partner. Orion is a globally operating Finnish pharmaceutical company. They develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of their pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others.
Orion primarily serves healthcare service providers and professionals such as specialists and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories.
Discover how Orion is empowering well-being and go visit their demo area, hosted in collaboration with the Healthware Group, designed to showcase Digital Therapeutics software solution ROHKEA™ (ODD-403) for Chronic Pain (DTxP), using Virtual Reality (VR). Join us at Frontiers Health 2022!